PRDX6_HUMAN - dbPTM
PRDX6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PRDX6_HUMAN
UniProt AC P30041
Protein Name Peroxiredoxin-6
Gene Name PRDX6
Organism Homo sapiens (Human).
Sequence Length 224
Subcellular Localization Cytoplasm . Lysosome . Also found in lung secretory organelles (lamellar bodies).
Protein Description Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Can reduce H(2)O(2) and short chain organic, fatty acid, and phospholipid hydroperoxides. Also has phospholipase activity, and can therefore either reduce the oxidized sn-2 fatty acyl grup of phospholipids (peroxidase activity) or hydrolyze the sn-2 ester bond of phospholipids (phospholipase activity). These activities are dependent on binding to phospholipids at acidic pH and to oxidized phospholipds at cytosolic pH. Plays a role in cell protection against oxidative stress by detoxifying peroxides and in phospholipid homeostasis..
Protein Sequence MPGGLLLGDVAPNFEANTTVGRIRFHDFLGDSWGILFSHPRDFTPVCTTELGRAAKLAPEFAKRNVKLIALSIDSVEDHLAWSKDINAYNCEEPTEKLPFPIIDDRNRELAILLGMLDPAEKDEKGMPVTARVVFVFGPDKKLKLSILYPATTGRNFDEILRVVISLQLTAEKRVATPVDWKDGDSVMVLPTIPEEEAKKLFPKGVFTKELPSGKKYLRYTPQP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
18PhosphorylationAPNFEANTTVGRIRF
CCCCCCCCCEEEEEE
29.8828857561
32PhosphorylationFHDFLGDSWGILFSH
EEHHHCCCEEEEECC
25.9622673903
44PhosphorylationFSHPRDFTPVCTTEL
ECCCCCCCCCEEHHH
21.0719664994
47S-nitrosylationPRDFTPVCTTELGRA
CCCCCCCEEHHHHHH
4.0325040305
48PhosphorylationRDFTPVCTTELGRAA
CCCCCCEEHHHHHHH
24.4421815630
49PhosphorylationDFTPVCTTELGRAAK
CCCCCEEHHHHHHHH
24.8823403867
56SumoylationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.17-
56UbiquitinationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.17-
56SumoylationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.17-
562-HydroxyisobutyrylationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.17-
56MalonylationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.1726320211
56AcetylationTELGRAAKLAPEFAK
HHHHHHHHHCHHHHH
44.1725953088
63UbiquitinationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.2321890473
63MethylationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.2319608861
63SumoylationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.2319608861
632-HydroxyisobutyrylationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.23-
63AcetylationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.2319608861
63SumoylationKLAPEFAKRNVKLIA
HHCHHHHHCCCEEEE
50.23-
72PhosphorylationNVKLIALSIDSVEDH
CCEEEEEECCCHHHH
18.4827251275
75PhosphorylationLIALSIDSVEDHLAW
EEEEECCCHHHHHHH
26.2428348404
83PhosphorylationVEDHLAWSKDINAYN
HHHHHHHCCCCCCCC
18.16-
84UbiquitinationEDHLAWSKDINAYNC
HHHHHHCCCCCCCCC
52.50-
84AcetylationEDHLAWSKDINAYNC
HHHHHHCCCCCCCCC
52.5026051181
89PhosphorylationWSKDINAYNCEEPTE
HCCCCCCCCCCCCCC
18.8321945579
91S-nitrosocysteineKDINAYNCEEPTEKL
CCCCCCCCCCCCCCC
4.00-
91S-nitrosylationKDINAYNCEEPTEKL
CCCCCCCCCCCCCCC
4.0019483679
91GlutathionylationKDINAYNCEEPTEKL
CCCCCCCCCCCCCCC
4.0022555962
95PhosphorylationAYNCEEPTEKLPFPI
CCCCCCCCCCCCCCE
49.3721945579
97AcetylationNCEEPTEKLPFPIID
CCCCCCCCCCCCEEC
65.0326051181
97UbiquitinationNCEEPTEKLPFPIID
CCCCCCCCCCCCEEC
65.03-
972-HydroxyisobutyrylationNCEEPTEKLPFPIID
CCCCCCCCCCCCEEC
65.03-
106MethylationPFPIIDDRNRELAIL
CCCEECCCCHHHHHH
40.12115488765
108MethylationPIIDDRNRELAILLG
CEECCCCHHHHHHHC
41.00115488757
122AcetylationGMLDPAEKDEKGMPV
CCCCHHHCCCCCCCC
73.6026051181
122SumoylationGMLDPAEKDEKGMPV
CCCCHHHCCCCCCCC
73.60-
122UbiquitinationGMLDPAEKDEKGMPV
CCCCHHHCCCCCCCC
73.60-
125SumoylationDPAEKDEKGMPVTAR
CHHHCCCCCCCCEEE
71.31-
125UbiquitinationDPAEKDEKGMPVTAR
CHHHCCCCCCCCEEE
71.3121906983
125AcetylationDPAEKDEKGMPVTAR
CHHHCCCCCCCCEEE
71.3126051181
125SumoylationDPAEKDEKGMPVTAR
CHHHCCCCCCCCEEE
71.31-
141UbiquitinationVFVFGPDKKLKLSIL
EEEECCCCCEEEEEE
64.24-
141AcetylationVFVFGPDKKLKLSIL
EEEECCCCCEEEEEE
64.2425953088
142AcetylationFVFGPDKKLKLSILY
EEECCCCCEEEEEEE
59.2324887509
142SumoylationFVFGPDKKLKLSILY
EEECCCCCEEEEEEE
59.23-
1442-HydroxyisobutyrylationFGPDKKLKLSILYPA
ECCCCCEEEEEEEEC
49.41-
144AcetylationFGPDKKLKLSILYPA
ECCCCCEEEEEEEEC
49.4125953088
146PhosphorylationPDKKLKLSILYPATT
CCCCEEEEEEEECCC
14.6820068231
149PhosphorylationKLKLSILYPATTGRN
CEEEEEEEECCCCCC
6.8028152594
152PhosphorylationLSILYPATTGRNFDE
EEEEEECCCCCCHHH
25.8628152594
153PhosphorylationSILYPATTGRNFDEI
EEEEECCCCCCHHHH
35.9328152594
155MethylationLYPATTGRNFDEILR
EEECCCCCCHHHHHH
38.25115488773
166PhosphorylationEILRVVISLQLTAEK
HHHHHHHHHEEECCC
9.8420068231
170PhosphorylationVVISLQLTAEKRVAT
HHHHHEEECCCCCCC
21.5821406692
177PhosphorylationTAEKRVATPVDWKDG
ECCCCCCCCCCCCCC
22.4619664994
1822-HydroxyisobutyrylationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.58-
182SumoylationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.58-
182MethylationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.58156701
182AcetylationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.5826051181
182SumoylationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.58-
182UbiquitinationVATPVDWKDGDSVMV
CCCCCCCCCCCEEEE
47.5821906983
186PhosphorylationVDWKDGDSVMVLPTI
CCCCCCCEEEEECCC
20.0321712546
188SulfoxidationWKDGDSVMVLPTIPE
CCCCCEEEEECCCCH
2.7221406390
192PhosphorylationDSVMVLPTIPEEEAK
CEEEEECCCCHHHHH
45.0320068231
199UbiquitinationTIPEEEAKKLFPKGV
CCCHHHHHHHCCCCC
53.9721906983
199SumoylationTIPEEEAKKLFPKGV
CCCHHHHHHHCCCCC
53.97-
199AcetylationTIPEEEAKKLFPKGV
CCCHHHHHHHCCCCC
53.9726051181
199SumoylationTIPEEEAKKLFPKGV
CCCHHHHHHHCCCCC
53.97-
200UbiquitinationIPEEEAKKLFPKGVF
CCHHHHHHHCCCCCE
63.51-
204SumoylationEAKKLFPKGVFTKEL
HHHHHCCCCCEECCC
61.44-
204UbiquitinationEAKKLFPKGVFTKEL
HHHHHCCCCCEECCC
61.44-
204SumoylationEAKKLFPKGVFTKEL
HHHHHCCCCCEECCC
61.44-
204AcetylationEAKKLFPKGVFTKEL
HHHHHCCCCCEECCC
61.4426051181
209AcetylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.8719608861
209SuccinylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.87-
209MalonylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.8726320211
2092-HydroxyisobutyrylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.87-
209SuccinylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.87-
209UbiquitinationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.8721890473
209SumoylationFPKGVFTKELPSGKK
CCCCCEECCCCCCCC
45.8719608861
213PhosphorylationVFTKELPSGKKYLRY
CEECCCCCCCCEEEE
75.7124719451
2152-HydroxyisobutyrylationTKELPSGKKYLRYTP
ECCCCCCCCEEEECC
42.45-
215AcetylationTKELPSGKKYLRYTP
ECCCCCCCCEEEECC
42.4521339330
216AcetylationKELPSGKKYLRYTPQ
CCCCCCCCEEEECCC
53.7121339330
217PhosphorylationELPSGKKYLRYTPQP
CCCCCCCEEEECCCC
10.4122210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
177TPhosphorylationKinaseMAPK1P28482
GPS
177TPhosphorylationKinaseMAPK-FAMILY-GPS
177TPhosphorylationKinaseMAPK-Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
47COxidation

9497358
177TPhosphorylation

26830860

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PRDX6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NCF2_HUMANNCF2physical
12121978
PRDX6_HUMANPRDX6physical
9587003
RAGP1_HUMANRANGAP1physical
22939629
TIM9_HUMANTIMM9physical
22939629
SUCB2_HUMANSUCLG2physical
22939629
SMAP_HUMANC11orf58physical
22939629
RHOA_HUMANRHOAphysical
22939629
VATA_HUMANATP6V1Aphysical
22939629
TPIS_HUMANTPI1physical
22939629
PREP_HUMANPITRM1physical
22939629
TMEDA_HUMANTMED10physical
22939629
TM189_HUMANTMEM189physical
22939629
PUR4_HUMANPFASphysical
22939629
RADI_HUMANRDXphysical
22939629
SSU72_HUMANSSU72physical
22939629
PRDX6_HUMANPRDX6physical
21988832
CASPA_HUMANCASP10physical
20829884
CASP8_HUMANCASP8physical
20829884
ALDR_HUMANAKR1B1physical
26344197
ASSY_HUMANASS1physical
26344197
CD2AP_HUMANCD2APphysical
26344197
ECI1_HUMANECI1physical
26344197
LGUL_HUMANGLO1physical
26344197
G6PI_HUMANGPIphysical
26344197
GRHPR_HUMANGRHPRphysical
26344197
SCOT1_HUMANOXCT1physical
26344197
PRDX2_HUMANPRDX2physical
26344197
PRDX5_HUMANPRDX5physical
26344197
STH_HUMANSTHphysical
16186110
1433E_HUMANYWHAEphysical
21346153
SFTA1_HUMANSFTPA1physical
16330552
GSTP1_HUMANGSTP1physical
16401067
PRDX6_HUMANPRDX6physical
16401067

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PRDX6_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63 AND LYS-209, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89, AND MASSSPECTROMETRY.

TOP